Elsevier

Metabolism

Volume 38, Issue 6, June 1989, Pages 586-589
Metabolism

A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy

https://doi.org/10.1016/0026-0495(89)90222-9Get rights and content

Abstract

Serum insulinlike growth factor-I (IGF-I) concentration was evaluated prospectively over two years in 35 diabetic patients with severe background or preproliferative retinopathy (group 1) and 24 diabetics with mild background retinopathy matched for age, sex, and glycemic control (group 2). In addition, 12 normal subjects were also studied to assess the variability of individual serum IGF-I levels over two years. Mean serum IGF-I (±SD) μg/I at entry, one year, and two years was not significantly different in the patient groups (157 ± 71 v 168 ± 77; 166 ± 78 v 159 ± 87; 143 ± 58 v 159 ± 67) or when compared with the normal subjects (181 ± 47, 188 ± 30; 221 ± 56). Eight patients in the preproliferative group and none in the mild background group developed proliferative retinopathy. In this subgroup developing retinal neovascularization, serum IGF-I at the time of the first appearance of retinal new vessels was significantly higher than 3 months (1 to 4 months) before the onset of proliferation (271 ± 94 v 196 ± 58; P = .036). Values at the time of proliferation were not, however, significantly different from the mean serum IGF-I value of all patients in group 1 and by 4 months (3 to 6 m) had returned to their previous values. Although a transient elevation of IGF-I occurs at the time of retinal new vessel formation, the rise in serum concentration is not sufficiently great or early enough to be of clinical value as a predictor of retinal neovascularization.

References (22)

  • BEK Klein et al.

    Diabetic retinopathy: Assessment of severity and progression

    Ophthalmology

    (1984)
  • DR Clemmons et al.

    Factors controlling blood concentration of somatomedin C

  • RL Hintz et al.

    Plasma somatomedin and growth hormone values in children with protein calorie malnutrition

    J Pediatr

    (1978)
  • TJ Merimee et al.

    Insulin-like growth factors: Studies in diabetics with and without retinopathy

    N Engl J Med

    (1983)
  • M Grant et al.

    Insulin-like growth factors in vitreous: Studies in control and diabetic subjects with neovascularisation

    Diabetes

    (1986)
  • PR Lamberton et al.

    Von Willebrand factor, fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy

    Diabetes

    (1984)
  • SL Hyer et al.

    Serum IGF-I concentration in diabetic retinopathy

    Diabetic Med

    (1988)
  • RC Baxter et al.

    Monoclonal antibody against human somatomedin C/insulin-like growth factor 1

    J Clin Endocrinol Metab

    (1982)
  • WH Daughaday et al.

    Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum

    J Clin Endocrinol Metab

    (1980)
  • SA Amiel et al.

    Effect of diabetes and its control on insulin-like growth factors in the young subjects with type 1 diabetes

    Diabetes

    (1984)
  • DR Powell et al.

    Serum somatomedin levels in adults with chronic renal failure: The importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum

    J Clin Endocrinol Metab

    (1986)
  • Cited by (54)

    • Growth hormone and insulin-like growth factor-I axis in type 1 diabetes

      2018, Growth Hormone and IGF Research
      Citation Excerpt :

      It was previously hypothesized that GH hypersecretion in T1D contributes to microangiopathic complications, and indeed studies have shown that T1D patients with GH deficiency have decreased rates of retinopathy [23,24]. However, other growth factors including IGF-I have also been implicated in microangiopathy in T1D [25,26]. TheT1D cohort who received higher dose of IGF-I in the ‘rhIGF-I in the IDDM Study group’ had worsening of early retinopathy [21].

    • An ocular view of the IGF-IGFBP system

      2013, Growth Hormone and IGF Research
      Citation Excerpt :

      Similarly, long term diabetes have revealed increased IGFBP-3 expression in human tears which can reduce IGF-IR phosphorylation and may be implicated in the pathogenesis of ocular surface complications of the cornea [79]. Studies have established that PDR and accelerated neovascularization is preceded by elevated IGF levels, however serum levels correlating to the pathogenesis of PDR remain controversial [38,80–83]. Serum levels of IGF-I was found to be decreased in retinopathy, nephropathy, and neuropathy [84–91].

    • Ocular Oxygenation and the Treatment of Diabetic Retinopathy

      2006, Survey of Ophthalmology
      Citation Excerpt :

      VEGF is probably most important,102 and in this article we use it to represent all of the hypoxia induced growth factors. Other candidates include insulin-like growth factor-1,17,60,64,95,97,99,149,154 basic fibroblast growth factors,59,103,122,133 platelet-derived growth factor,37,65,67,117 hepatocyte growth factor,14,27,43,96,126 placenta growth factor,63,168 and angiopoietin.50,101 Pigment epithelial growth factor is anti-angiogenic and is downregulated by hypoxia.25,94,132,145

    View all citing articles on Scopus

    Supported by the British Diabetic Association and by a locally organized grant from the Hammersmith Hospital.

    View full text